Rongfang X. He

Hengyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma.

LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma.

Journal: Journal for immunotherapy of cancer

Published: August 05, 2026

ENO1 lactylation drives bevacizumab resistance through metabolic reprogramming and angiogenesis in ovarian cancer.

ENO1 lactylation drives bevacizumab resistance through metabolic reprogramming and angiogenesis in ovarian cancer.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: January 03, 2026

DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC.

DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 09, 2025

Diffusion attention expert model for predicting and semi-automatic localizing STAS in lung cancer histopathological images.

Diffusion attention expert model for predicting and semi-automatic localizing STAS in lung cancer histopathological images.

Journal: Nature communications

Published: April 25, 2025

Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer.

Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 12, 2025

Pathology-interpretable radiomic model for predicting clinical outcome in patients with osteosarcoma: a retrospective, multicenter study.

Pathology-interpretable radiomic model for predicting clinical outcome in patients with osteosarcoma: a retrospective, multicenter study.

Journal: BMC medicine

Published: August 20, 2024

Causal associations between human gut microbiota and hemorrhoidal disease: A two-sample Mendelian randomization study.

Causal associations between human gut microbiota and hemorrhoidal disease: A two-sample Mendelian randomization study.

Journal: Medicine

Published: March 29, 2024

Utility of immunocytochemistry in diagnosing abdominopelvic washings from patients undergoing radical surgery for endometrial cancer.

Utility of immunocytochemistry in diagnosing abdominopelvic washings from patients undergoing radical surgery for endometrial cancer.

Journal: CytoJournal

Published: February 04, 2024

SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.

SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.

Journal: Frontiers in immunology

Published: January 13, 2024

Utility of SHOX2 and RASSF1A gene methylation detection on the residual cytology material from endobronchial ultrasound-guided transbronchial needle aspiration.

Utility of SHOX2 and RASSF1A gene methylation detection on the residual cytology material from endobronchial ultrasound-guided transbronchial needle aspiration.

Journal: CytoJournal

Published: December 28, 2023

Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer.

Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer.

Journal: Clinical breast cancer

Published: November 27, 2023

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: November 09, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026